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Abstract
Rationale High levels of impulsivity are a core symptom of
psychiatric disorders such as ADHD, mania, personality
disorders and drug addiction. The effectiveness of drugs
targeting dopamine (DA), noradrenaline (NA) and/or
serotonin (5-HT) in the treatment of impulse control
disorders emphasizes the role of monoaminergic neuro-
transmission in impulsivity. However, impulsive behavior is
behaviorally and neurally heterogeneous, and several
caveats remain in our understanding of the role of mono-
amines in impulse control.
Objectives This study aims to investigate the role of DA,
NA and 5-HT in two main behavioral dimensions of
impulsivity.
Methods The effects of selective DA (GBR12909; 2.5–
10 mg/kg), NA (atomoxetine; 0.3–3.0 mg/kg) and 5-HT
(citalopram; 0.3–3.0 mg/kg) reuptake inhibitors as well as
amphetamine (0.25–1.0 mg/kg) were evaluated on impulsive
action in the five-choice serial reaction time task (5-CSRTT)
and impulsive choice in the delayed reward task (DRT). In the
5-CSRTT, neuropharmacological challenges were performed
under baseline and long intertrial interval (ITI) conditions to
enhance impulsive behavior in the task.
Results Amphetamine and GBR12909 increased impulsive
action and perseverative responding and decreased accura-
cy and response latency in the 5-CSRTT. Atomoxetine
increased errors of omission and response latency under
baseline conditions in the 5-CSRTT. Under a long ITI,
atomoxetine also reduced premature and perseverative
responding and increased accuracy. Citalopram improved
impulse control in the 5-CSRTT. Amphetamine and
GBR12909, but not citalopram or atomoxetine, reduced
impulsive choice in the DRT.
Conclusions Elevation of DA neurotransmission increases
impulsive action and reduces impulsive choice. Increasing
NA or 5-HT neurotransmission reduces impulsive action.
Keywords Impulsivity.Delayed reward.Five-choice serial
reaction time task.Dopamine.Serotonin.Noradrenaline
Introduction
Exaggerated impulsive behavior very often has undesirable
consequences. As such, impulsivity is prominent in the
symptomatology of a variety of psychiatric disorders such as
attention deficit/hyperactivity disorder (ADHD), drug addic-
tion, problem gambling, mania and personality disorders
(American Psychiatric Association 2000; Chamberlain and
Sahakian 2007;M o e l l e re ta l .2001). Moreover, impulsivity
may be a behavioral marker for enhanced vulnerability to
drug addiction. Poor response inhibition or enhanced impul-
sive decision making predisposes adolescents for smoking,
alcoholism and substance abuse (Audrain-McGovern et al.
2009;N i g ge ta l .2006). Consistently, animal studies have
shown that high impulsivity predicts the vulnerability to
alcohol consumption, cocaine self-administration and
nicotine-seeking behavior (Dalley et al. 2007; Diergaarde et
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widely recognized that impulsivity consists of various, mostly
independent behavioral dimensions that can be neuroanatomi-
cally and neuropharmacologically dissociated (Dalley et al.
2011; Eagle and Baunez 2010;E v e n d e n1999; Pattij and
Vanderschuren 2008;W i n s t a n l e y2011). In general, two main
subtypes of impulsive behavior are distinguished, i.e.,
impulsive choice and impulsive action. Impulsive choice
refers to the inability to delay gratification, which is
behaviorally apparent as a preference for a small, immediate
gain over a larger reward that one has to wait for. Impulsive
action comprises behavior resulting from a deficit in the
ability to withhold responding or stop ongoing behavior. Both
behavioral subtypes of impulsivity appear in the patient
population and these can be studied in preclinical models
with high translational value (Evenden 1999; Moeller et al.
2001; Solanto et al. 2001; Winstanley 2011).
Different classes of drugs are used in the treatment of
disorders characterized by disrupted impulse regulation such
as ADHD, personality disorders and problem gambling. The
psychostimulant drugs amphetamine (Adderall™) and meth-
ylphenidate (Ritalin™, Concerta™) are the first-choice
treatment for ADHD, whereas the selective noradrenaline
reuptake inhibitor atomoxetine (Strattera®) is a widely used
alternative (Biederman and Faraone 2005). The therapeutic
use of these drugs has sparked great interest in the role of
monoaminergic neurotransmission in impulsivity. The pri-
mary mode of action of amphetamine is to enhance
monoaminergic neurotransmission by blocking the reuptake
and evoking the release of dopamine (DA), noradrenaline
(NA) and, to a lesser extent, serotonin (5-hydroxytryptamine,
5-HT) (Kuczenski and Segal 1989; Kuczenski et al. 1995;
Ritz and Kuhar 1989; Rothman et al. 2001;S e i d e ne ta l .
1993;S u l z e re ta l .1995). Administration of amphetamine
has been shown to decrease impulsive choice in delay-
discounting paradigms (Barbelivien et al. 2008; Cardinal et
al. 2000; De Wit et al. 2002; Isles et al. 2003; Richards et al.
1999; Sun et al. 2011; Van Gaalen et al. 2006b;W a d ee ta l .
2000; Winstanley et al. 2003, but see Evenden and Ryan
1996) but to increase premature responding, an index of
impulsive action, in the five-choice serial reaction time task
(5-CSRTT; Cole and Robbins 1987; 1989;H a r r i s o ne ta l .
1997;M u r p h ye ta l .2008; Paterson et al. 2011;P a t t i je ta l .
2007; Sun et al. 2011; Van Gaalen et al. 2006a). Pharmaco-
logical analysis of the effects of amphetamine has indicated
that DA neurotransmission plays an important, opposing role
in the modulation of impulsive action and impulsive choice
(Cole and Robbins 1989; Pattij et al. 2007; van Gaalen et al.
2006a, 2006b, 2009). Atomoxetine is a potent NA reuptake
inhibitor with no appreciable affinity for the DA or 5-HT
transporter (Bolden-Watson and Richelson 1993), which has
been shown to be effective in the treatment of ADHD
(Kratochvil et al. 2006;S i m p s o na n dP e r r y2003; Spencer et
al. 2002; Wilens et al. 2006). Although selective inhibition of
NA reuptake has been reported to have beneficial effects on
impulsive action in the 5-CSRTT (Blondeau and Dellu-
Hagedorn 2007; Navarra et al. 2008; Paine et al. 2007;
Paterson et al. 2011;R o b i n s o ne ta l .2008; Sun et al. 2011;
Van Gaalen et al. 2006a), its effects on impulsive choice are
inconclusive (Robinson et al. 2008; Sun et al. 2011;V a n
Gaalen et al. 2006b). Interestingly, 5-HT was the first
neurotransmitter system to be implicated in impulsivity
(Linnoila et al. 1983; Soubrié 1986). Selective 5-HT
reuptake inhibitors (SSRIs) are not regularly prescribed as
therapeutic drugs for ADHD (Biederman and Faraone 2005;
Elia et al. 1999; Fone and Nutt 2005; Kutcher et al. 2004),
although they are used for the treatment of other disorders
associated with poor impulse control such as problem
gambling, sexual addiction, personality disorders and impul-
sive aggression (Coccaro and Kavoussi 1997; Hollander and
Rosen 2000). Remarkably, the effects of SSRIs on different
forms of impulsive behavior have not been characterized in
depth (Bari et al. 2009; Evenden and Ryan 1996).
Although the role of monoamine neurotransmission in
impulsive behavior has been widely investigated, several
caveats remain. First, as mentioned above, the consequen-
ces of selective blockade of the 5-HT transporter for
impulsive behavior are largely unknown. Second, beneficial
effects of selective NA reuptake inhibitors on impulsive
action (as assessed in the 5-CSRTT and stop signal task)
have been consistently reported by different studies, but its
effects on impulsive choice are inconclusive. Third, in
studies on impulsive action using the 5-CSRTT, well-
trained animals are used, which often display very low
levels of impulsivity. This makes it easy to detect impair-
ments in impulse control but leaves relatively little room to
observe reductions in premature responding, which is most
relevant from a therapeutic point of view. The present study
sought to further characterize the role of monoamine
neurotransmission in impulsive behavior, taking these
caveats into account. To that aim, we investigated the
effects of selective inhibitors of the reuptake of DA
(GBR12909), NA (atomoxetine) and 5-HT (citalopram) on
two main behavioral dimensions of impulsivity in rats.
Impulsive action was studied using the 5-CSRTT (Carli et
al. 1983; Robbins 2002), and the delayed reward task
(DRT; Evenden and Ryan 1996) was used to measure
impulsive choice. Amphetamine was also included as its
effects on impulsive behavior have been well described
(Eagle and Baunez 2010; Pattij and Vanderschuren 2008).
To increase the possibility to observe drug-induced reduc-
tions in impulsive action, we performed neuropharmaco-
logical challenges in the 5-CSRTT under both baseline as
well as long intertrial interval (ITI) conditions. The use of a
long ITI, in which the animal unexpectedly has to wait
longer for the instruction signal to appear, enhances levels
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Navarra et al. 2008; Paterson et al. 2011). Not only does a
long ITI evoke higher levels of premature responding, it
may also be that performance under baseline conditions
relies on different neural and cognitive processes than
responding under novel, challenging circumstances. For
example, NA neurotransmission appears to be especially
engaged when task contingencies unexpectedly change
(Cole and Robbins 1992; Dalley et al. 2001; Sirviö et al.
1993). Thus, drug effects under baseline and long ITI
conditions in the 5-CSRTT may be qualitatively or
quantitatively different.
Materials and methods
Subjects
Male Lister Hooded rats (Harlan CPB, Horst, The Nether-
lands), weighing 200–250 g at the beginning of the
experiment, were housed two per cage under reversed
lighting conditions (lights on from 19.00 to 07.00 h). After
2 weeks of habituation, rats were placed on a restricted diet
of 14 g of standard rat chow per day and body weights were
monitored on a weekly basis. Feeding occurred in the rats'
home cages at the end of the experimental day. All
experiments were approved by the Animal Ethics Committee
of Utrecht University and were conducted in agreement with
Dutch laws (Wet op de Dierproeven, 1996) and European
regulations (Guideline 86/609/EEC).
Behavioral apparatus
Behavioral testing for all experiments was conducted in 16
identical operant conditioning chambers (30.5×24×21 cm;
Med Associates, St. Albans, VT, USA) enclosed in sound
attenuating boxes. The boxes were equipped with a fan to
provide ventilation and to mask extraneous noise. Set in the
curved wall of each box was an array of five holes. Each nose
pokeunitwas equippedwithaninfrareddetectorand a yellow
light-emitting diode stimulus light. Food pellets (45 mg,
Formula P; Bio-Serv) could be delivered at the opposite wall
via a dispenser. The chamber could be illuminated by a white
houselightmountedinthecenteroftheroof.Onlinecontrolof
the apparatusanddatacollectionwereperformedusingMED-
PC version 1.17 (Med Associates).
Behavioral procedures
A detailed description of the 5-CSRTT and DRT procedure
has been provided previously (Van Gaalen et al. 2006a;V a n
Gaalen et al. 2006b, respectively). Separate groups of
animals were trained for each experiment. For both
behavioral paradigms, similar habituation and magazine
training protocols were followed. This protocol consisted of
a habituation exposure to the operant chambers for two
daily 30-min sessions, during which sucrose pellets were
placed in the response holes and food magazine. Subse-
quently, in the next two sessions, a total of 75 pellets were
delivered with a random interval to allow the animals to
associate the sound of pellet delivery with reward. This
procedure was followed by magazine shaping, in which
animals were trained to make a nose poke into an
illuminated response hole to earn reward. The spatial
location of the stimulus lights was adjusted according to
the experimental paradigm. Each session of magazine
training consisted of 100 trials and lasted approximately
30 min. Five sessions were scheduled per week (one
session per day, Monday–Friday) during the dark phase of
the light/dark cycle.
Five-choice serial reaction time task
Rats were trained to detect and respond to a brief visual
stimulus presented randomly in one of the five nose poke
units to obtain a food reward. A trial started with an ITI of
5 s, followed by 1-s illumination of one of the five
apertures and 2-s limited hold. Following a nose poke in
the illuminated aperture, i.e., a correct response, animals
were rewarded with the delivery of one food pellet (45 mg,
Formula P, Research Diets) in the food magazine. During
the training session, stimulus duration was set at 32 s and
was gradually decreased over sessions to 1 s until animals
reached stable baseline performance (accuracy, >80%
correct choice and <20% errors of omission). Each daily
session consisted of 100 discrete trials or 30 min, which-
ever occurred first. A nose-poke response into a non-
illuminated aperture, i.e., an incorrect response as well as
failure to respond within 5 s after the onset of the stimulus,
i.e., an error of omission, resulted in no food delivery and a
time-out period with the house light extinguished for 5 s.
Nose pokes made during the ITI, i.e., before the onset of the
stimulus (premature responses) were recorded as a measure of
impulsivity and resulted in a 5 s time-out and no food reward.
Perseverative responses, i.e., repeated responding during the
presentation of the stimulus, were measured but did not have
any programmed consequences. The following behavioral
measureswererecorded:(1)prematureresponses,i.e.,number
of responses into one of the holes during the ITI preceding
stimulus presentation; (2) accuracy, i.e., percentage of correct
responses [(number correct responses) / (correct+incorrect
responses)×100]; (3) latency of correct responses, i.e., the
mean time between stimulus onset and nose poke in the
illuminated unit; (4) omission errors, i.e., the total number of
omittedtrialsduringasession;and(5)perseverativeresponses
after correct choice.
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conditions, a cohort of rats was used for pharmacological
manipulation under long ITI conditions. During these
sessions, the ITI was extended to 7 s to provoke impulsive
behavior (Dalley et al. 2002). The long ITI session
consisted of 100 trials (ITI 7 s, stimulus duration 0.5 s)
per session and was repeated once a week. The long ITI
days were at all times preceded and followed by two
baseline days (ITI 5 s, stimulus duration 0.5 s) to avoid
habituation to the long ITI.
Delayed reward paradigm
Rats were faced with a choice between a small, immediate
food reward and a larger but delayed food reward.
Ultimately, the delayed option is more beneficial, but the
subjective value of the large food reward declines with
increasing delay to its delivery (Logue 1988).
In the final stage of the task, a session was divided into
five blocks of 12 trials. Each block started with two forced
trials in which, after initiating the trial by a nose poke into
the center hole, either the left or the right hole was
illuminated in a counterbalanced fashion. For the next 10
trials, the animals had a free choice and both the left and
right units were illuminated. Nose poking into one position
resulted in the immediate delivery of a small reinforcer (one
food pellet), whereas a nose poke into the other position
resulted in the delivery of a large, but delayed, reinforcer
(four food pellets). Over sessions, the delays for the large
reinforcer were progressively increased within a session
from 0 to 10, 20, 40 and 60 s per block. After delivery of
the reinforcer or the choice phase time elapsed, an ITI
commenced until the next trial started. As the trial time was
fixed, the ITI duration depended on the duration of the
delay. The positions associated with the small and large
reinforcers were always the same for each individual but
counterbalanced for the group. The behavioral measure to
assess task performance, i.e., the percentage preference for
the large reinforcer as a function of delay, was calculated as
the [(number of choices for the large reinforcer) / (number
choices large+small reinforcers)×100]. Furthermore, no
response during the choice phase within 10 s was counted
as an omission and the total number of omitted choice trials
per block of 10 trials within a session was calculated.
Drugs
(+)-Amphetamine sulphate was purchased from O.P.G.
(Utrecht, The Netherlands). GBR12909 dihydrochloride,
atomoxetine hydrochloride and citalopram hydrobromide
were obtained from Tocris Bioscience (UK). All drug doses
were calculated as salt, dissolved in 0.9% saline (amphet-
amine, atomoxetine, and citalopram) or sterile water
(GBR12909). Drugs were freshly prepared each day before
testingandinjectedintraperitoneally(i.p.)inavolumeof1ml/
kg body weight. Drug tests were conducted on Tuesdays and
Fridayswith baselinetrainingsessionsonthe other weekdays.
Before the first test day, all animals had been habituated twice
to i.p. saline injections. Drugs were administered according to
a Latinsquaredesignandeachanimalreceiveda maximum of
two different drugs. In addition, in a subgroup of rats
pharmacological manipulations were tested in the 5-CSRTT
underalongITIof7sonceaweekaccordingtoaLatinsquare
designwithbaselinetrainingsessions(intertrialintervalof5s)
in between.
Statistical analysis
All data are presented as means and standard errors of the
mean and analyzed using SPSS for Windows, version 15.0.
The data of the delayed reward task were subjected to an
arcsin transformation before statistical analysis (McDonald
2009). In the DRT, animals that did not show a delay-
dependent curve in their choice behavior (0% choice for
large reward at 0 s delay, 100% choice for large reward at 40
and 60 s delay) were excluded from the experiment. Data
were analyzed by one- (5-CSRTT) or two-factor (DRT)
repeated-measures ANOVAs with drug treatment (5-CSRTT,
DRT) and delay to large reinforcer (DRT) as within-subjects
variables. If the outcome of the repeated-measures ANOVA
yielded significant effects of dose or dose×delay at p<0.05
level, further post-hoc analysis was performed using paired
samples t-tests. Pharmacological effects on 5-CSRTT perfor-
mance under a long ITI were analyzed using paired samples
t-tests (vehicle versus drug treatment).
Results
Effect of amphetamine and monoamine reuptake inhibitors
on 5-CSRTT performance under baseline conditions
As depicted in Fig. 1a and Table 1, amphetamine
significantly increased the number of premature responses
and perseverative responses in the 5-CSRTT [F(3,45)=
13.12, p<0.001 and F(3,45)=3.64, p<0.05, respectively].
Post-hoc analysis revealed that the increase of premature
and perseverative responses was significant at all tested
doses (p<0.01 and p<0.05, respectively). In addition to the
effect on impulsivity, systemic administration of amphet-
amine reduced accuracy, i.e., percentage of correct
responses at all doses [F(3,45)=8.82, p<0.001], whereas
the response latency was only reduced at a dose of 0.5 mg/
kg (Table 1)[ F(3,45)=3.37, p<0.05]. Errors of omission
were differentially affected by amphetamine; as 0.25 mg/kg
of amphetamine reduced the amount of errors of omission,
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and 1 mg/kg of amphetamine resulted in a significant
increase (Table 1)[ F(3,45)=10.49, p<0.001].
Systemic administration of the selective DA reuptake
i n h i b i t o rG B R 1 2 9 0 9r e s u l t e di ne n h a n c e dp r e m a t u r ea n d
perseverative responses at a dose of 10 mg/kg (Fig. 1b
and Table 1)[ F(3,45)=8.46, p<0.007 and F(3,45)=10.26,
p<0.004, respectively]. At this dose, the percentage of
correct responses and response latency were reduced
(Table 1)[ F(3,45)=6.02, p<0.01 and F(3,45)=3.93,
p=0.01, respectively]. GBR12909 had no effect on errors
of omission [F(3,45)=2.23, NS].
Atomoxetine, the selective NA reuptake inhibitor,
enhanced the errors of omission and slowed response
latency at all tested doses without affecting impulsive
behavior (Fig. 1c and Table 1)[ F(3,45)=26.43, p<0.001,
F(3,45)=23.22, p<0.001, F(3,45)=2.54, NS, respectively].
The other parameters of 5-CSRTT performance were
unaffected by atomoxetine treatment under baseline con-
ditions [correct responses: F(3,45)=2.23, NS and persever-
ative responses: F(3,45)=0.8, NS].
Premature responding was decreased after treatment with
the selective 5-HT reuptake inhibitor citalopram at the
intermediate dose of 1.0 mg/kg (Fig. 1d)[ F(3,45)=2.98,
p<0.05], whereas the response latency was increased at a
dose of 1.0 mg/kg and 3.0 mg/kg [F(3,45)=2.79, p=0.05].
Further comparisons indicated that accuracy, errors of
omissions and perseverative responses were unaffected by
citalopram [F(3,45)=0.23, NS, F(3,45)=0.99, NS, F(3,45)=
1.97, NS, respectively].
Effect of amphetamine and monoamine reuptake inhibitors
on 5-CSRTT performance under long ITI conditions
Under long ITI conditions in the 5-CSRTT, the effects of
monoamine reuptake inhibitors were tested at a dose that
affected impulsive behavior under baseline conditions, i.e.,
10 mg/kg GBR12909 and 1 mg/kg citalopram. For atom-
oxetine, which did not alter impulsive behavior under
baseline conditions, the highest dose was used (i.e., 3 mg/
kg). An intermediate dose of amphetamine (0.5 mg/kg) was
used as this dose had no effect on the errors of omission
under baseline conditions but did markedly increase
impulsive behavior in the 5-CSRTT (Table 1).
Similar to baseline conditions, amphetamine (0.5 mg/kg)
and GBR12909 (10 mg/kg) increased the amount of
premature and perseverative responses and attenuated
accuracy under long ITI conditions (Fig. 2a,b )[ p r e m a t u r e
responses: df=15, t=−4.07, p=0.001 and df=14, t=−3.49,
p=0.01, perseverative responses: df=15, t=−3.21, p<0.01
and df=14, t=−2.50, p<0.05, correct responses: df=15, t=
2.70, p<0.05 and df=14, t=2.52, p<0.05, respectively]. In
addition, GBR12909 (10 mg/kg) decreased response latency,
whereas amphetamine had no effect on this parameter [df=
14, t=2.91, p=0.01 and df=15, t=−0.44, NS, respective-
ly]. No effect of amphetamine and GBR12909 was
Fig. 1 Effects of amphetamine
(a), the selective DA reuptake
inhibitor GBR12909 (b), the
selective NA reuptake inhibitor
atomoxetine (c) and the
selective 5-HT reuptake
inhibitor citalopram (d)o n
premature responding, i.e.,
impulsive action under baseline
conditions (visual stimulus
presented 5 s after trial
initiation) in the 5-CSRTT. In
total, n=16 animals were
included in the analysis. Asterisk
indicates p<0.05 and two
asterisks indicates p<0.01
compared to vehicle treatment
(paired samples t-test). All data
are expressed as mean±SEM
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df=14, t=0.66, NS].
Atomoxetine (3 mg/kg) reduced premature and persev-
erative responding under long ITI conditions (Fig. 2c)[ df=
15, t=6.0, p<0.001 and df=15, t=4.47, p<0.001, respec-
tively]. Additional comparisons revealed that all other
parameters of 5-CSRTT were enhanced by atomoxetine
under these conditions (Fig. 2c) [correct responses: df=15,
t=−2.97, p=0.01; omissions: df=15, t=−2.33 p<0.05;
response latency: df=15, t=−2.26, p<0.05].
Premature and perseverative responses were both re-
duced by citalopram (1 mg/kg) pretreatment under long ITI
conditions (Fig. 2d) [premature responses: df=15, t=4.28,
p=0.001, perseverative responses: df=15, t=2.49, p<0.05].
Under these conditions, citalopram did not affect accuracy,
errors of omission and response latency [correct responses:
df=15, t=−0.22, NS, omissions: df=15, t=−0.19, NS and
response latency: df=15, t=1.26, NS].
Effect of amphetamine and monoamine reuptake inhibitors
on impulsive choice in the DRT
Overall, animals showed a delay-dependent decline in their
choice behavior for the large, delayed reward [vehicle, delay:
F(4,48)=31.49, p<0.001]. Amphetamine significantly
enhanced the preference for the large delayed reward [dose:
F(3,36)=3.11, p<0.05; dose×delay: F(12,144)=1.33, NS],
and post-hoc analysis revealed that this effect was significant
for all doses of amphetamine at the 40-s delay and for 0.5
and 1 mg/kg amphetamine at a delay of 60 s (Fig. 3a).
The selective DA reuptake inhibitor GBR12909 also
increased the preference for the larger delayed reward
[dose: F(3,39)=11.07, p<0.001; dose×delay: F(12,156)=
2.29, p=0.01]. Post-hoc analysis of the data showed a
significant effect of 10 mg/kg of GBR12909 on all delays,
i.e., 10, 20, 40 and 60 s (Fig. 3b). At a dose of 5 mg/kg,
GBR12909 resulted in an increased preference for the large
reward at the delay of 10 and 20 s (Fig. 3b).
The selective NA reuptake inhibitor atomoxetine did not
alter choice behavior in the DRTat any delay [dose: F(3,39)=
0.31, NS; dose×delay: F(12,156)=1.64, NS].
The selective 5-HT reuptake inhibitor citalopram also did
notaffectchoicebehaviorintheDRT(Fig.3d)[ d o s e :F(3,39)=
1.27, NS; dose×delay: F(12,156)=1.11, NS].
Discussion
In order to advance our understanding of the role of
monoamine neurotransmission in impulse control, the
Table 1 Effects of amphetamine, GBR12909, atomoxetine and
citalopram on behavioral performance (accuracy, omissions, prema-
ture and perseverative responses, response latency) under baseline
conditions (visual stimulus presented 5 s after trial initiation) in the 5-
CSRTT. In total, n=16 animals were included in the analysis. *p<0.05
and **p<0.01 compared to vehicle treatment (paired samples t-test).
All data are expressed as mean±SEM
Correct responses Errors of omission Premature responses Perseverative responses Response latency (s)
Amphetamine
Veh 90.8±1.4 17.9±1.6 6.3±1.0 13.8±2.4 0.71±0.03
0.25 mg/kg 85.2±2.2* 12.4±1.3* 18.4±4.4** 23.7±4.9* 0.66±0.02
0.5 mg/kg 82.9±2.3* 16.2±2.3 24.0±4.1** 23.8±5.7* 0.6±0.02*
1.0 mg/kg 79.1±2.3* 32.5±5.2** 36.3±6.0** 29.2±6.6* 0.71±0.03
GBR12909
Veh 90.7±1.1 14.6±2.1 5.3±0.8 6.7±1.1 0.67±0.02
2.5 mg/kg 91.2±1.2 15.8±2.7 4.8±0.7 5.9±0.7 0.67±0.02
5.0 mg/kg 89.0±1.4 11.6±1.8 8.9±2.4 7.9±1.6 0.64±0.02*
10.0 mg/kg 85.3±2.3** 10.2±1.9 29.9±8.2** 21.4±4.9** 0.61±0.02**
Atomoxetine
Veh 91.0±1.5 18.4±2.2 6.4±1.5 14.6±4.2 0.73±0.03
0.3 mg/kg 94.6±1.4 25.8±2.5* 3.2±1.2 11.0±2.3 0.81±0.04**
1.0 mg/kg 94.3±1.0 33.4 ±3.0** 3.5±0.9 10.9±1.9 0.84±0.04**
3.0 mg/kg 94.5 ±1.6 44.3±2.8** 3.5±0.9 10.2±2.4 0.96±0.04**
Citalopram
Veh 91.7±1.0 12.8±2.1 5.1±0.8 7.0±1.7 0.66±0.02
0.3 mg/kg 91.7±1.3 15.8±2.6 4.8±0.9 7.1±1.1 0.68±0.02
1.0 mg/kg 92.2±1.2 16.4±2.6 2.6 ±0.4* 4.1±1.1 0.69±0.02*
3.0 mg/kg 92.5±1.2 16.6±2.2 3.1±0.7 7.4±1.5 0.70±0.02*
318 Psychopharmacology (2012) 219:313–326present study investigated the effects of selective mono-
amine reuptake inhibitors on two behavioral dimensions of
impulsivity, i.e., impulsive action in the 5-CSRTT and
impulsive choice in the DRT. Besides comparing three
selective monoamine reuptake inhibitors and amphetamine
in two separate measures of impulsivity within a single
study, we aimed to address several outstanding questions
with regard to monoamine neurotransmission and impulsive
behavior. Thus, we have shown that the 5-HT reuptake
blocker citalopram selectively reduces premature respond-
ing in the 5-CSRTT but does not affect impulsive choice in
the DRT. In addition, the NA reuptake inhibitor atom-
oxetine reduced impulsive action primarily when levels of
premature responding were high (i.e., under a long ITI) but
amphetamine (mg/kg) atomoxetine  (mg/kg) citalopram (mg/kg) GBR12909 (mg/kg)
Fig. 2 Effects of amphetamine (a), the selective DA reuptake
inhibitor GBR12909 (b), the selective NA reuptake inhibitor atom-
oxetine (c) and the selective 5-HT reuptake inhibitor citalopram (d)o n
5-CSRTT performance under long ITI conditions (visual stimulus
presented 7 s after trial initiation). In total, n=15 animals were
included in the analysis. Asterisk indicates p<0.05 and two asterisks
indicates p<0.01 compared to vehicle treatment (paired samples t-
test). All data are expressed as mean±SEM
Psychopharmacology (2012) 219:313–326 319did not affect impulsive choice. Furthermore, using a long
ITI in the 5-CSRTT, we show that amphetamine and the
DA reuptake blocker GBR12909 enhance, and that atom-
oxetine and citalopram reduce impulsive action. Thus, the
effects of these drugs on impulsive behavior were not
qualitatively different under baseline and long ITI con-
ditions. Consistent with previous findings, we also show
that amphetamine and the selective dopamine reuptake
blocker GBR12909 decreased impulsive choice.
Amphetamine has been consistently reported to disrupt
inhibitory control, i.e., the ability to withhold responding in
the 5-CSRTT (Cole and Robbins 1987; 1989; Harrison et
al. 1997; Murphy et al. 2008; Paterson et al. 2011; Pattij et
al. 2007; Sun et al. 2011; Van Gaalen et al. 2006a). Our
findings confirmed this disinhibitory effect of amphet-
amine, which increased the number of premature responses
in the 5-CSRTT at all doses tested (0.25–1 mg/kg). In
addition to response inhibition, the 5-CSRTT provides
several relatively independent measures of performance
such as task efficiency, motivation and attentional capacity
(Robbins 2002). Alongside its effects on premature
responding, amphetamine also attenuated accuracy, en-
hanced perseverative responding, reduced response latency
(at 0.5 mg/kg only) and had biphasic effects on errors of
omission. The effects of amphetamine were comparable
under baseline and long ITI conditions. Although not
universally reported as effects of amphetamine in the 5-
CSRTT, the present profile of effects is highly comparable
to previous reports (reduced accuracy: Cole and Robbins
1989; Harrison et al. 1997; Pattij et al. 2007; Sun et al.
2011; increased omissions: Cole and Robbins 1987; 1989;
Harrison et al. 1997; Murphy et al. 2008; Sun et al. 2011;
Van Gaalen et al. 2006a; and faster response latency: Cole
and Robbins 1987; 1989; Harrison et al. 1997; Pattij et al.
2007).
Amphetamine increases extracellular levels of DA, NA,
and, to a lesser extent, 5-HT by binding to monoamine
transporters on the cell membrane and on intracellular
neurotransmitter storage vesicles as a false substrate thereby
promoting reverse transport of cytosolic transmitter stores
(Seiden et al. 1993; Sulzer et al. 1995). Comparable to
amphetamine, GBR12909 also enhanced premature
responding, reduced accuracy, enhanced perseverative
responding and reduced response latencies under both
baseline and long ITI conditions. This indicates that the
effects of amphetamine in the 5-CSRTT—except for the
increases in errors of omission at the highest dose—are
mediated by DA (Fernando et al. 2011; Seu et al. 2009;V a n
Gaalen et al. 2006a). Pharmacological studies have shown
that the amphetamine-induced augmentation of premature
responding in the 5-CSRTT largely depends on DA D2
receptor stimulation in the nucleus accumbens (Cole and
Robbins 1989; Pattij et al. 2007; Van Gaalen et al. 2006a;
2009). Conversely, reducing DA neurotransmission using
DA receptor antagonists or low doses of DA D2 receptor
agonists, which suppress DA neurotransmission by stimu-
Fig. 3 Effects of amphetamine
(a), the selective DA reuptake
inhibitor GBR12909 (b), the
selective NA reuptake inhibitor
atomoxetine (c) and the
selective 5-HT reuptake
inhibitor citalopram (d) on the
percentage choice for the large
reinforcer in the delayed reward
paradigm. In total, n=13–15
animals were included in the
analysis. Asterisk indicates
p<0.05 and two asterisks
indicates p<0.01 compared to
vehicle treatment (paired
samples t-test). All data are
expressed as mean±SEM
320 Psychopharmacology (2012) 219:313–326lating presynaptic D2 autoreceptors, has been found to
reduce impulsive action in the 5-CSRTT (Fernando et al.
2011; Koskinen and Sirvio 2001; Lecourtier and Kelly
2005;P a s s e t t ie ta l .2003; Van Gaalen et al. 2006a;
Winstanley et al. 2010). DA-mediated increases in the
salience of the reward-related cues in the task and/or
increased response vigor by amphetamine may explain its
effects in the 5-CSRTT (Berridge and Robinson 1998;
Cardinal et al. 2002). This results in a higher rate of
performance reflected by a lower amount of errors of
omission and faster response latency, albeit at the expense
of task accuracy and reduced impulse control. This is
consistent with the well-established effect of psychostimu-
lant drugs on behavior, i.e., a general enhancement of the
rate of behavioral performance causing short and simple
behaviors to dominate the behavioral repertoire and cutting
short of complex chains of behavior (Lyon and Robbins
1975). At the highest dose of amphetamine (1 mg/kg), this
results in a more general disruption of task performance in
the 5-CSRTT. Interestingly, the increase in errors of
omission at this highest dose likely relies on NA rather
than DA neurotransmission because this effect was mim-
icked by atomoxetine but not GBR12909. This indicates
that at higher doses, the effects of amphetamine on 5-
CSRTT performance are mediated by increases in both DA
and NA neurotransmission.
Neurobiological and pharmacological data provide evi-
dence for the hypothesis that NA plays a key role in both
the etiology and treatment of ADHD (Arnsten, 2009;
Biederman and Spencer 1999). Moreover, clinical observa-
tions have shown that a subgroup of patients who do not
respond to psychostimulants, such as amphetamine and
methylphenidate, do respond to atomoxetine (Newcorn et
al. 2008). Selective inhibition of NA reuptake by atom-
oxetine reduced premature responding in the 5-CSRTT
under long ITI conditions. NA neurotransmission has been
implicated in the regulation of behavior under novel or
demanding circumstances (Aston-Jones and Cohen 2005;
Cole and Robbins 1992; Dalley et al. 2001; McGaughy et
al. 2002; Sirviö et al. 1993). In the 5-CSRTT, PFC NA
levels rise when task contingencies are changed (Dalley et
al. 2001), and cortically NA-depleted rats are slower to
adapt to changing task requirements (Milstein et al. 2007).
Our observation that atomoxetine was predominantly
effective under (relatively) novel and challenging, long
ITI conditions corresponds with these findings. Interestingly,
previous studies that reported reduced impulsivity in the 5-
CSRTTunder baseline conditions after atomoxetine treatment
useda shorter stimulusduration(0.5s versus1s inthe present
study; Blondeau and Dellu-Hagedorn 2007; Robinson et al.
2008; Sun et al. 2011). Under these more demanding test
conditions, levels of premature responses are higher, and
performance may depend on NA signaling to a greater
extent. An alternative, not necessarily inconsistent explana-
tion, is that the absence of an effect of atomoxetine on
impulsivity under baseline conditions in our study was due
to a floor effect so that the increase in premature responses
under long ITI conditions provided a larger window to
observe a decrease in impulsivity. Interestingly, atomoxetine
indeed seems to reduce impulsive action in the 5-CSRTT
primarily in rats characterized by high levels of premature
responses (Blondeau and Dellu-Hagedorn 2007; Fernando et
al. 2011) or high levels of premature responding due to
prolonged ITI durations (Navarra et al. 2008;P a t e r s o ne ta l .
2011). In these studies, no effect of selective blockade of NA
by atomoxetine on impulsive action was observed in low
impulsive rats (Fernando et al. 2011), efficient rats (Blondeau
and Dellu-Hagedorn 2007) or at short intertrial interval
durations (4- and 5-s ITI: Paterson et al. 2011; Navarra et
al. 2008) consistently reflected by low baseline levels of
premature responding.
Atomoxetine also increased errors of omission and
lengthened response latencies, under both baseline and
long ITI conditions, suggesting that this drug somewhat
slowed down the performance in the 5-CSRTT. These
effects of atomoxetine are consistent with previous findings
with noradrenaline reuptake inhibitors, especially at higher
doses (Blondeau and Dellu-Hagedorn 2007; Fernando et al.
2011; Navarra et al. 2008; Paine et al. 2007; Sun et al.
2011; Van Gaalen et al. 2006a). Motivational deficits do not
likely underlie these increased omissions and response
latencies because NA reuptake inhibitors have been shown
to increase reinforcement rates in differential reinforcement
of low responding schedules (O'Donnell et al. 2005).
Interestingly, under the challenging long ITI conditions,
accuracy was improved by systemic atomoxetine (see also
Navarra et al. 2008) supporting the role of NA neurotrans-
mission in behavioral vigilance (Arnsten 2004; Aston-Jones
and Cohen 2005). Together, these data suggest that NA
neurotransmission is particularly involved in the modula-
tion of behavior in the 5-CSRTT under circumstances when
task performance is suboptimal, either as a result of
demanding task requirements or as a result of inherent
individual differences in behavior. Increasing NA neuro-
transmission then leads to a more conservative pattern of
responding whereby task accuracy and impulse control
increase but speed of performance declines somewhat.
The serotonin reuptake inhibitor citalopram resulted in a
decrease in premature responding in the 5-CSRTT at an
intermediate dose of 1 mg/kg. A similar improvement in
impulse control was observed under long ITI conditions. In
contrast to amphetamine, GBR12909 and atomoxetine, the
effect of citalopram on premature responding was quite
selective as accuracy and errors of omission were not
affected. Our finding is in line with the observation that
enhanced 5-HT transmission in 5-HT transporter knockout
Psychopharmacology (2012) 219:313–326 321rats is associated with reduced premature responding in the
5-CSRTT (Homberg et al. 2007). Conversely, forebrain 5-
HT depletion significantly increases premature responding
in the 5-CSRTT (Harrison et al. 1997; Winstanley et al.
2004). Together, these studies suggest that increasing 5-HT
activity may be a possible mechanism for attenuation of
impulsive action. In vivo microdialysis within the medial
prefrontal cortex has shown a positive relationship between
premature responding and basal 5-HT levels although no
alteration in 5-HT efflux during task performance was
found (Dalley et al. 2002). These results indicate a role for
tonic 5-HT levels in the prefrontal cortex in impulsive
regulation in the 5-CSRTT. However, 5-HT depletion using
5,7-DHT infusion into the medial prefrontal cortex did not
affect impulsive action in the 5-CSRTT (Fletcher et al.
2009). Thus, the role of 5-HT in impulse action is not
straightforward, which is likely related to the great diversity
of 5-HT receptors, and the fact that 5-HT modulates
impulsive action through different brain regions (Eagle
and Baunez 2010; Pattij and Vanderschuren 2008).
In contrast to its effects on impulsive behavior in the
5CSRTT, amphetamine had beneficial effects on impulsive
choice, exemplified by the enhanced ability of the animals to
choose a large, delayed reward instead of a small, immediate
reward. Our finding is in keeping with previous studies in
mice, rats and humans (Barbelivien et al. 2008; De Wit et al.
2002; Isles et al. 2003; Richards et al. 1999; Van Gaalen et
al. 2006b;W a d ee ta l .2000; Winstanley et al. 2003)a l t h o u g h
this effect of amphetamine is found to be dose-, baseline-
and context-dependent (Barbelivien et al. 2008; Cardinal et
al. 2000; Evenden and Ryan 1996; Isles et al. 2003). In this
study, we showed that impulsive choice was decreased after
blockade of DA by GBR12909 but not selective blockade of
NA or 5-HT by atomoxetine or citalopram, respectively. An
important regulatory role of DA in impulsive choice has
been proposed before (Wade et al. 2000; Van Gaalen et al.
2006b) as the improved impulsive choice by amphetamine
was blocked by the DA D2 receptor antagonist eticlopride
(Van Gaalen et al. 2006b).
In the present study, atomoxetine did not affect impulsive
choice. In agreement with our findings, Sun et al. (2011)
found no effect on impulsive choice following atomoxetine
administration. In contrast, Robinson et al. (2008)r e p o r t e d
that atomoxetine reduced impulsive choice whereby the
increase in percentage choice for the large reward after
atomoxetine treatment was most pronounced at the shorter
delays. The somewhat less selective NA reuptake blocker
desipramine had no consistent effect in the DRT (Van Gaalen
et al. 2006b). Together, these data suggest that acute
enhancement of NA neurotransmission has, at best, modest
effects on impulsive choice in a delayed reward task.
In vivo microdialysis experiments have shown that 5-HT
release within the medial prefrontal cortex correlates with
performance in the DRT (Winstanley et al. 2006) indicating
that 5-HT release is essential for proper delay discounting
judgments. However, inconsistent effects of forebrain 5-HT
depletions on impulsive choice have been found (Bizot et
al. 1999; Mobini et al. 2000; Winstanley et al. 2003; 2004;
Wogar et al. 1993). Likewise, inconsistent effects of 5-HT
depletion have been found in humans as tryptophan depletion
increased delay discounting in healthy volunteers in one
study (Schweighofer et al. 2008) but not another (Crean et al.
2002). In the present study, selective inhibition of 5-HT
reuptake by citalopram did not affect choice behavior in the
delayed reward task. In agreement with our findings,
Evenden and Ryan (1996) found that the tolerance to delay
of gratification was not affected by acute administration of
citalopram or imipramine. Early studies on the neural
mechanisms of impulsive behavior have implicated low
levels of 5-HT in impulsivity (Linnoila et al. 1983; Soubrié
1986). Together with previous findings discussed here, our
data indicate that elevation of 5-HT levels by SSRIs has a
beneficial effect on impulsive action but not impulsive choice
suggesting that the early association of 5-HTwith impulsivity
relates more to the former than to the latter.
The present study aimed to pinpoint the separate roles of
three monoamine neurotransmitters in two forms of
impulsive behavior using selective DA, NA and 5-HT
reuptake blockers. Two limitations to this approach should
be mentioned. First, although GBR12909, atomoxetine and
citalopram display low affinity for the other monoamine
transporters (Fone and Nutt 2005; Rothman et al. 2001),
transporter-selective reuptake inhibitors are not necessarily
transmitter-selective reuptake inhibitors. DA reuptake in the
striatum depends primarily on the DA transporter, whereas
DA reuptake in the prefrontal cortex depends on both the
NA transporter and the DA transporter due to the low
density of the DA transporter in this area (Carboni et al.
2006; Morón et al. 2002; Tanda et al. 1997). Atomoxetine,
therefore, indirectly boosts prefrontal cortical DA via its
effects on the NA transporter but it does not modulate DA
levels in the striatum (Bymaster et al. 2002). Thus, a
contribution of prefrontal DA to the effects of atomoxetine
in the 5-CSRTT cannot be excluded. However, the COMT
inhibitor tolcapone that selectively modulates DA, but not
NA, did not attenuate impulsive action in rats that exhibited
suboptimal 5-CSRTT performance suggesting that cortical
DA does not contribute to the effects of atomoxetine on
impulsive action (Paterson et al. 2011). Second, through
their downstream effects, increased synaptic DA, NA and
5-HT levels can indirectly alter the activity of other
neurotransmitter systems (e.g., Di Giovanni et al. 1999;
Vanderschuren et al. 1999) so that coordinated activity of
multiple neurotransmitter systems mediates adaptive behav-
ior. For example, with regard to impulse control, 5-HT–DA
interactions have been shown to be involved in impulsive
322 Psychopharmacology (2012) 219:313–326choice in rats. Thus, forebrain 5-HT lesions attenuated the
ability of amphetamine to decrease impulsive behavior in a
delay-discounting task, particularly in rats with high baseline
levels of impulsivity, but did not themselves alter delay-
discounting performance (Winstanley et al. 2003). Therefore,
involvement of neurotransmitters other than DA, NA and 5-
HT, respectively, in the behavioral effects of GBR12909,
atomoxetine and citalopram cannot be excluded.
In conclusion, the neuropharmacological manipulations
presented here indicate a differential contribution of DA, NA
and 5-HTin the modulation oftwo dimensions ofimpulsivity.
Inhibition of the reuptake of DA exerted opposite effects on
impulsive action (increase) and impulsive choice (decrease),
whereas inhibition of NA and 5-HT reuptake reduced
impulsive action but not impulsive choice. The current study,
therefore, supports the well-established notion of the hetero-
genous nature of impulsivity (Dalley et al. 2011; Eagle and
Baunez 2010; Evenden 1999; Pattij and Vanderschuren
2008). The existence of independent processes of impulse
control is exemplified in the psychiatric population, although
it is difficult to relate certain forms of impulsivity with
particular disorders (Moeller et al. 2001; Solanto et al. 2001;
Sonuga-Barke 2003). Nevertheless, deficits in one of the
subtypes of impulsivity or genetic variation in monoamine
signaling (e.g., Colzato et al. 2010; Hamidovic et al. 2009)
may contribute to the differential responsiveness and
effectiveness of drug treatments in impulse control disorders.
As such, understanding the contribution of different neuro-
transmitter systems to distinct forms of impulsivity may
contribute to the development of selectively tailored phar-
macotherapeutic treatments of impulse control disorders.
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